Caricamento...
Development of CDK2 and CDK5 Dual Degrader TMX-2172
Cyclin-dependent kinase 2 (CDK2) is a potential therapeutic target for the treatment of cancer. Development of CDK2 inhibitors has been extremely challenging as its ATP-binding site shares high similarity with CDK1, a related kinase whose inhibition causes toxic effects. Here, we report the developm...
Salvato in:
| Pubblicato in: | Angew Chem Int Ed Engl |
|---|---|
| Autori principali: | , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7703486/ https://ncbi.nlm.nih.gov/pubmed/32415712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/anie.202004087 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|